Mission statement

The Mater Institute of Research and Therapy for Blood Cancers (MIRT) is a new organization which aims to drive progress and innovation in the understanding and treatment of blood cancers, through the exchange of ideas and the pursuit of excellence in research and development.

Our goals are: